27-hydroxycholesterol has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rocha, G; Sierralta, W; Valladares, L | 1 |
| Umetani, M | 1 |
| DuSell, CD; McDonnell, DP | 1 |
1 review(s) available for 27-hydroxycholesterol and Cardiovascular Diseases
| Article | Year |
|---|---|
Re-adopting classical nuclear receptors by cholesterol metabolites.
Topics: Animals; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Humans; Hydroxycholesterols; Liver X Receptors; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Sterols | 2016 |
2 other study(ies) available for 27-hydroxycholesterol and Cardiovascular Diseases
| Article | Year |
|---|---|
[27- Hydroxycholesterol reverses estradiol induced inhibition of platelet aggregation in postmenopausal women].
Topics: Aged; Blood Platelets; Cardiovascular Diseases; Collagen; Estradiol; Estrogen Antagonists; Estrogens; Female; Humans; Hydroxycholesterols; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Postmenopause; Reference Values; Risk Factors; Statistics, Nonparametric | 2016 |
27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling.
Topics: Animals; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Disease Models, Animal; Humans; Hydroxycholesterols; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction; Transcription, Genetic | 2008 |